SLC5A2 and diabetic ketoacidosis: In individuals with inadequate insulin, low sugar intake, volume depletion, heavy alcohol intake, or concurrent illnesses, euglycemic diabetic ketoacidosis, an uncommon but severe contrary effect of SGLT2 inhibitors, might develop [23].